Methotrexate
NDC 0143-9367, Methotrexate, injection, powder, lyophilized, for solution, from Hikma Pharmaceuticals USA Inc..
- Product NDC
- 0143-9367
- Status
- Listed
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRA-ARTERIAL, INTRAMUSCULAR, INTRATHECAL, INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA040632
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0143-9367 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- METHOTREXATE1 g/1
Pharmacologic classes
Folate Analog Metabolic Inhibitor [EPC]; Folic Acid Metabolism Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0143-9367-01 | 00143936701 | 1 VIAL in 1 BOX (0143-9367-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/8593f7fc-eabe-44ae-bb05-b3d7d408e4f7Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0143-9367
Use it
Look up 0143-9367 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0143-9367 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0143-9367. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.